open
SYMBIOTEC Symbiotec Pharmalab IPO
Symbiotec Pharmalab is a pharmaceutical and biotechnology company with over 30 years of experience. It mainly manufactures Corticosteroid and Steroidal Hormone APIs, which are important ingredients used to make medicines.
Advertisement (Slot: header)
Price Band
🔴
Lot Size
0 Shares
Issue Size
Approx ₹1,757 Crores
Current GMP
₹185 (Sep 1)
IPO Timeline
Open DateSeptember 1, 2026
Close DateSeptember 1, 2026
Basis of AllotmentTBA
Listing DateJanuary 1, 2026
Subscription Status
Overall subscription
Promoters
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 21,633,968 | 34.47% | – | -% |
| Others* | 40,047,528 | 65.53% | – | -% |
| Total | 6,16,81,496 | 100% | 6,32,02,757 | 100% |
Objects of the Issue
- JM Financial Ltd.
- Avendus Capital Pvt. Ltd.
- Motilal Oswal Investment Advisors Ltd.
- Nomura Financial Advisory & Securities (India) Pvt. Ltd.